Nucleoporin 153 deficiency in adult neural stem cells defines a pathological protein-network signature and defective neurogenesis in a mouse model of AD.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
03 Sep 2024
Historique:
received: 05 10 2023
accepted: 17 06 2024
medline: 4 9 2024
pubmed: 4 9 2024
entrez: 3 9 2024
Statut: epublish

Résumé

Reduction of adult hippocampal neurogenesis is an early critical event in Alzheimer's disease (AD), contributing to progressive memory loss and cognitive decline. Reduced levels of the nucleoporin 153 (Nup153), a key epigenetic regulator of NSC stemness, characterize the neural stem cells isolated from a mouse model of AD (3×Tg) (AD-NSCs) and determine their altered plasticity and gene expression. Nup153-regulated mechanisms contributing to NSC function were investigated: (1) in cultured NSCs isolated from AD and wild type (WT) mice by proteomics; (2) in vivo by lentiviral-mediated delivery of Nup153 or GFP in the hippocampus of AD and control mice analyzing neurogenesis and cognitive function; (3) in human iPSC-derived brain organoids obtained from AD patients and control subjects as a model of neurodevelopment. Proteomic approach identified Nup153 interactors in WT- and AD-NSCs potentially implicated in neurogenesis regulation. Gene ontology (GO) analysis showed that Nup153-bound proteins in WT-NSCs were involved in RNA metabolism, nuclear import and epigenetic mechanisms. Nup153-bound proteins in AD-NSCs were involved in pathways of neurodegeneration, mitochondrial dysfunction, proteasomal processing and RNA degradation. Furthermore, recovery of Nup153 levels in AD-NSCs reduced the levels of oxidative stress markers and recovered proteasomal activity. Lentiviral-mediated delivery of Nup153 in the hippocampal niche of AD mice increased the proliferation of early progenitors, marked by BrdU/DCX and BrdU/PSANCAM positivity and, later, the integration of differentiating neurons in the cell granule layer (BrdU/NeuN Our data suggest that the positive effect of Nup153 on neurogenesis is based on a complex regulatory network orchestrated by Nup153 and that this protein is a valuable disease target.

Sections du résumé

BACKGROUND BACKGROUND
Reduction of adult hippocampal neurogenesis is an early critical event in Alzheimer's disease (AD), contributing to progressive memory loss and cognitive decline. Reduced levels of the nucleoporin 153 (Nup153), a key epigenetic regulator of NSC stemness, characterize the neural stem cells isolated from a mouse model of AD (3×Tg) (AD-NSCs) and determine their altered plasticity and gene expression.
METHODS METHODS
Nup153-regulated mechanisms contributing to NSC function were investigated: (1) in cultured NSCs isolated from AD and wild type (WT) mice by proteomics; (2) in vivo by lentiviral-mediated delivery of Nup153 or GFP in the hippocampus of AD and control mice analyzing neurogenesis and cognitive function; (3) in human iPSC-derived brain organoids obtained from AD patients and control subjects as a model of neurodevelopment.
RESULTS RESULTS
Proteomic approach identified Nup153 interactors in WT- and AD-NSCs potentially implicated in neurogenesis regulation. Gene ontology (GO) analysis showed that Nup153-bound proteins in WT-NSCs were involved in RNA metabolism, nuclear import and epigenetic mechanisms. Nup153-bound proteins in AD-NSCs were involved in pathways of neurodegeneration, mitochondrial dysfunction, proteasomal processing and RNA degradation. Furthermore, recovery of Nup153 levels in AD-NSCs reduced the levels of oxidative stress markers and recovered proteasomal activity. Lentiviral-mediated delivery of Nup153 in the hippocampal niche of AD mice increased the proliferation of early progenitors, marked by BrdU/DCX and BrdU/PSANCAM positivity and, later, the integration of differentiating neurons in the cell granule layer (BrdU/NeuN
CONCLUSIONS CONCLUSIONS
Our data suggest that the positive effect of Nup153 on neurogenesis is based on a complex regulatory network orchestrated by Nup153 and that this protein is a valuable disease target.

Identifiants

pubmed: 39227892
doi: 10.1186/s13287-024-03805-1
pii: 10.1186/s13287-024-03805-1
doi:

Substances chimiques

Nuclear Pore Complex Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

275

Subventions

Organisme : Alzheimer's Association
ID : AARG-19 614919
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Snyder JS, Kee N, Wojtowicz JM. Effects of adult neurogenesis on synaptic plasticity in the rat dentate gyrus. J Neurophysiol. 2001;85(6):2423–31.
doi: 10.1152/jn.2001.85.6.2423 pubmed: 11387388
Toni N, Schinder AF. Maturation and Functional Integration of New Granule Cells into the adult Hippocampus. Cold Spring Harb Perspect Biol. 2015;8(1):a018903.
doi: 10.1101/cshperspect.a018903 pubmed: 26637288
Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 2010;11(5):339–50.
doi: 10.1038/nrn2822 pubmed: 20354534 pmcid: 2886712
Kempermann G, Gage FH. Genetic determinants of adult hippocampal neurogenesis correlate with acquisition, but not probe trial performance, in the water maze task. Eur J Neurosci. 2002;16(1):129–36.
doi: 10.1046/j.1460-9568.2002.02042.x pubmed: 12153537
Jurkowski MP, Bettio L, Patten EKW, Yau A, Gil-Mohapel SY. Beyond the Hippocampus and the SVZ: adult neurogenesis throughout the brain. Front Cell Neurosci. 2020;14:576444.
doi: 10.3389/fncel.2020.576444 pubmed: 33132848 pmcid: 7550688
Bennett L, Yang M, Enikolopov G, Iacovitti L. Circumventricular organs: a novel site of neural stem cells in the adult brain. Mol Cell Neurosci. 2009;41(3):337–47.
doi: 10.1016/j.mcn.2009.04.007 pubmed: 19409493 pmcid: 2697272
Falnikar A, Stratton J, Lin R, Andrews CE, Tyburski A, Trovillion VA, et al. Differential Response in Novel Stem Cell niches of the brain after cervical spinal cord Injury and Traumatic Brain Injury. J Neurotrauma. 2018;35(18):2195–207.
doi: 10.1089/neu.2017.5497 pubmed: 29471717 pmcid: 6119227
DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32.
doi: 10.1186/s13024-019-0333-5 pubmed: 31375134 pmcid: 6679484
Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in Alzheimer’s disease: a review. 3 Biotech. 2022;12(2):55.
doi: 10.1007/s13205-022-03123-4 pubmed: 35116217 pmcid: 8807768
Moreno-Jimenez EP, Flor-Garcia M, Terreros-Roncal J, Rabano A, Cafini F, Pallas-Bazarra N, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med. 2019;25(4):554–60.
doi: 10.1038/s41591-019-0375-9 pubmed: 30911133
Arber C, Lovejoy C, Harris L, Willumsen N, Alatza A, Casey JM, et al. Familial Alzheimer’s disease mutations in PSEN1 lead to premature human stem cell neurogenesis. Cell Rep. 2021;34(2):108615.
doi: 10.1016/j.celrep.2020.108615 pubmed: 33440141 pmcid: 7809623
Demars M, Hu YS, Gadadhar A, Lazarov O. Impaired neurogenesis is an early event in the etiology of familial Alzheimer’s disease in transgenic mice. J Neurosci Res. 2010;88(10):2103–17.
doi: 10.1002/jnr.22387 pubmed: 20209626 pmcid: 3696038
Rodriguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, et al. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer’s disease. PLoS ONE. 2008;3(8):e2935.
doi: 10.1371/journal.pone.0002935 pubmed: 18698410 pmcid: 2492828
Zeng Q, Zheng M, Zhang T, He G. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer’s disease. Neuroscience. 2016;314:64–74.
doi: 10.1016/j.neuroscience.2015.11.054 pubmed: 26639620
Jakovcevski M, Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med. 2012;18(8):1194–204.
doi: 10.1038/nm.2828 pubmed: 22869198 pmcid: 3596876
Schoenfelder S, Fraser P. Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet. 2019;20(8):437–55.
doi: 10.1038/s41576-019-0128-0 pubmed: 31086298
Colussi C, Grassi C. Epigenetic regulation of neural stem cells: the emerging role of nucleoporins. Stem Cells. 2021;39(12):1601–14.
doi: 10.1002/stem.3444 pubmed: 34399020
Kehat I, Accornero F, Aronow BJ, Molkentin JD. Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins. J Cell Biol. 2011;193(1):21–9.
doi: 10.1083/jcb.201101046 pubmed: 21464227 pmcid: 3082185
Nanni S, Re A, Ripoli C, Gowran A, Nigro P, D’Amario D, et al. The nuclear pore protein Nup153 associates with chromatin and regulates cardiac gene expression in dystrophic mdx hearts. Cardiovasc Res. 2016;112(2):555–67.
doi: 10.1093/cvr/cvw204 pubmed: 28513807
Kuhn TM, Pascual-Garcia P, Gozalo A, Little SC, Capelson M. Chromatin targeting of nuclear pore proteins induces chromatin decondensation. J Cell Biol. 2019;218(9):2945–61.
doi: 10.1083/jcb.201807139 pubmed: 31366666 pmcid: 6719443
Lupu F, Alves A, Anderson K, Doye V, Lacy E. Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. Dev Cell. 2008;14(6):831–42.
doi: 10.1016/j.devcel.2008.03.011 pubmed: 18539113 pmcid: 2495767
Toda T, Hsu JY, Linker SB, Hu L, Schafer ST, Mertens J, et al. Nup153 interacts with Sox2 to Enable Bimodal Gene Regulation and maintenance of neural progenitor cells. Cell Stem Cell. 2017;21(5):618–34. e7.
doi: 10.1016/j.stem.2017.08.012 pubmed: 28919367
Jacinto FV, Benner C, Hetzer MW. The nucleoporin Nup153 regulates embryonic stem cell pluripotency through gene silencing. Genes Dev. 2015;29(12):1224–38.
doi: 10.1101/gad.260919.115 pubmed: 26080816 pmcid: 4495395
Kadota S, Ou J, Shi Y, Lee JT, Sun J, Yildirim E. Nucleoporin 153 links nuclear pore complex to chromatin architecture by mediating CTCF and cohesin binding. Nat Commun. 2020;11(1):2606.
doi: 10.1038/s41467-020-16394-3 pubmed: 32451376 pmcid: 7248104
Leone L, Colussi C, Gironi K, Longo V, Fusco S, Li Puma DD, et al. Altered Nup153 expression impairs the function of cultured hippocampal neural stem cells isolated from a mouse model of Alzheimer’s disease. Mol Neurobiol. 2019;56(8):5934–49.
Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75(17):4646–58.
doi: 10.1021/ac0341261 pubmed: 14632076
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25–9.
doi: 10.1038/75556 pubmed: 10802651 pmcid: 3037419
Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–62.
doi: 10.1093/nar/gkv1070 pubmed: 26476454
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90–7.
doi: 10.1093/nar/gkw377 pubmed: 27141961 pmcid: 4987924
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
doi: 10.1101/gr.1239303 pubmed: 14597658 pmcid: 403769
Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer’s disease. Biochim Biophys Acta. 2000;1502(1):139–44.
doi: 10.1016/S0925-4439(00)00040-5 pubmed: 10899439
Veeraval L, O’Leary CJ, Cooper HM. Adherens junctions: guardians of cortical development. Front Cell Dev Biol. 2020;8:6.
Kjell J, Fischer-Sternjak J, Thompson AJ, Friess C, Sticco MJ, Salinas F, et al. Defining the adult neural stem cell niche proteome identifies key regulators of adult neurogenesis. Cell Stem Cell. 2020;26(2):277–93 e8.
Jorgens DM, Inman JL, Wojcik M, Robertson C, Palsdottir H, Tsai WT, et al. Deep nuclear invaginations are linked to cytoskeletal filaments – integrated bioimaging of epithelial cells in 3D culture. J Cell Sci. 2017;130(1):177–89.
Malhas A, Goulbourne C, Vaux DJ. The nucleoplasmic reticulum: form and function. Trends Cell Biol. 2011;21(6):362–73.
Corbeil D, Santos MF, Karbanova J, Kurth T, Rappa G, Lorico A. Uptake and fate of extracellular membrane vesicles: nucleoplasmic reticulum-associated late endosomes as a new gate to intercellular communication. Cells. 2020;9(9).
Misrani A, Tabassum S, Yang L. Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease. Front Aging Neurosci. 2021;13:617588.
Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426(6968):895–9.
Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer’s disease. J Neurochem. 2003;85(1):115–22.
Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer’s disease. J Neurochem. 2000;75(1):436–9.
Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769–80.
Wang Z, Yu K, Tan H, Wu Z, Cho JH, Han X, et al. 27-Plex tandem mass tag mass spectrometry for profiling brain proteome in Alzheimer’s disease. Anal Chem. 2020;92(10):7162–70.
Bonet-Costa V, Pomatto LC, Davies KJ. The proteasome and oxidative stress in Alzheimer’s disease. Antioxid Redox Signal. 2016;25(16):886–901.
Okano H, Sawamoto K. Neural stem cells: involvement in adult neurogenesis and CNS repair. Philos Trans R Soc Lond B Biol Sci. 2008;363(1500):2111–22.
Raja WK, Mungenast AE, Lin YT, Ko T, Abdurrob F, Seo J, et al. Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer’s disease phenotypes. PLoS One. 2016;11(9):e0161969.
Meyer K, Feldman HM, Lu T, Drake D, Lim ET, Ling KH, et al. REST and neural gene network dysregulation in iPSC models of Alzheimer–s disease. Cell Rep. 2019;26(5):1112–27 e9.
Zhao J, Davis MD, Martens YA, Shinohara M, Graff-Radford NR, Younkin SG, et al. APOE epsilon4/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet. 2017;26(14):2690–700.
Hazawa M, Ikliptikawati DK, Iwashima Y, Lin DC, Jiang Y, Qiu Y, et al. Super-enhancer trapping by the nuclear pore via intrinsically disordered regions of proteins in squamous cell carcinoma cells. Cell Chem Biol. 2024;31(4):792–804 e7.
Santana DA, Smith MAC, Chen ES. Histone modifications in Alzheimer’s disease. Genes (Basel). 2023;14(2).

Auteurs

Claudia Colussi (C)

Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI) - CNR , National Research Council, Via dei Taurini 19, Rome, 00185, Italy. claudia.colussi@cnr.it.
Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy. claudia.colussi@cnr.it.

Alessia Bertozzi (A)

Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI) - CNR , National Research Council, Via dei Taurini 19, Rome, 00185, Italy.
Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.

Lucia Leone (L)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Marco Rinaudo (M)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Raimondo Sollazzo (R)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.

Federica Conte (F)

Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI) - CNR , National Research Council, Via dei Taurini 19, Rome, 00185, Italy.

Elena Paccosi (E)

Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI) - CNR , National Research Council, Via dei Taurini 19, Rome, 00185, Italy.

Luca Nardella (L)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.

Giuseppe Aceto (G)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Domenica Donatella Li Puma (DDL)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Cristian Ripoli (C)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Maria Gabriella Vita (MG)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Camillo Marra (C)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Marcello D'Ascenzo (M)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Claudio Grassi (C)

Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH